Holmes Biopharma, Inc.
OTC Bulletin Board : HLMB

Holmes Biopharma, Inc.

October 11, 2005 09:00 ET

Holmes Herbs, Inc.: Qualia Expanding Clinical Research Facilities

SCOTTSDALE, ARIZONA--(CCNMatthews - Oct. 11, 2005) - Holmes Herbs, Inc., (OTCBB:HMHB), announced today that its clinical research partner, Qualia Clinical Research Services Inc. ("Qualia"), is developing a new clinical research center.

This new facility is designed to conduct Phase I, Phase II and Bioequivalence clinical trials with state of the art equipment and experienced staff. It is projected to be completed and operating by February 2006.

"Our new clinic will be a world class facility. It will allow us to conduct clinical trials according to the guidelines provided by Therapeutic Product Directorate (TPD) Canada, Food and Drug Administration (FDA) USA, and European Regulatory Agencies European Union. This will be our first large scale clinic, allowing Qualia to take on bigger, more profitable research contracts." stated Dr. Sohail Khattak, President and CEO of Qualia.

Holmes Herbs Inc. is acquiring Qualia, a transaction expected to close on or before November 30, 2005.

On behalf of the Board of Directors

John F. Metcalfe, President and CEO

Certain statements in this press release constitute "forward looking statements" within the meaning of the United States Securities Legislation. The Company's actual results could differ from those in the forward-looking statements. Do not construe this information as investment advice. This is not a solicitation to buy or sell securities. This does not purport to be a complete analysis of the Company. Investing in securities is speculative and carries a high degree of risk. Past performance does not guarantee future results. Readers should consult their own independent advisers with any investment, including any contemplated investment. All information contained in this press release should be independently investigated. This press release contains forward-looking statements. These remarks involve risks and uncertainties. Risks are not limited to quarterly fluctuations in results or the companies' management of growth and competition. Other risks are detailed in the Company's SEC filings. Actual results may differ materially from such information set forth herein.

Contact Information

  • Holmes Herbs, Inc.
    John F. Metcalfe
    President and CEO
    (206) 245-4779
    ir@holmesherbs.com
    or
    Holmes Herbs, Inc.
    8655 East Via De Ventura
    Suite G-200
    Scottsdale, Arizona 85258